Clinical Trial Update: Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial update for aztreonam for inhalation solution (AZLI) in treating exacerbations of cystic fibrosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Aztreonam for inhalation solution (aztreonam for inhalation solution)

Snippet

Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust | Conditions: Cystic Fibrosis, Infection | Phase 4 | Status: COMPLETED